Questions Answered on ART Safety and Tolerability in Aging Patients and Populations With Cardiometabolic Toxicities
Hear from expert faculty as they answer questions and discuss key considerations when evaluating potential ARV-related toxicities in special populations, including aging patients and populations with cardiometabolic toxicities.
Decera Clinical Education Infectious Disease Podcast · Marta Boffito MD PhD FRCP, Jens Lundgren MD DMSc
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Marta Boffito, MD, PhD, FRCP, and Jens D. Lundgren, MD, DMSc, address key considerations when evaluating antiretroviral therapy safety and tolerability in aging patients and those with possible cardiometabolic toxicities, including:
- Monitoring for cardiometabolic syndromes (eg, lipid panels, coronary artery calcification scores)
- Approaching antiretroviral-related weight gain in clinical practice
- Interpreting results from RESPOND on cardiovascular risk with integrase strand transfer inhibitors
- Collaborating with other specialties (eg, cardiologists, dietitians) to provide a multidisciplinary approach for managing comorbidities, including prevention and management
Faculty:
Marta Boffito, MD, PhD, FRCP
Consultant Physician/Professor
HIV/Research
Chelsea and Westminster Hospital
Imperial College London
London, United Kingdom
Jens D. Lundgren, MD, DMSc
Professor
Rigshospital, University of Copenhagen
Director
Centre of Excellence for Health, Immunity and Infection (CHIP)
Rigshospital, University of Copenhagen
Copenhagen, Denmark
Link to full program:
http://bit.ly/3PM3nYe
Link to downloadable slides:
http://bit.ly/3WgYycz
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.